BiondVax Of Israel Says Phase II Trial Of Universal Flu Drug Passed Test
This article was originally published in PharmAsia News
Executive Summary
Israel’s BiondVax said a Phase II trial of its universal influenza vaccine showed it had no side effects as it activated immune systems.